BioGraphene Relocates to New Headquarters

2021
Written By BioGraphene

BioGraphene Inc. announced the relocation of its headquarters and R&D center into B-2F, Advanced Institute of Convergence Technology in Suwon, Korea. The new R&D center is equipped with a state-of-the-art pilot manufacturing facility for graphene quantum dots, which will be employed throughout pre-clinical studies.

BioGraphene
Previous

BioGraphene Appoints Dr. Yhun Yhong Sheen as Scientific Advisor
Next

BioGraphene Announces Publication in Nano Letters on the Potential of Graphene Quantum Dots as a Therapy for Niemann-Pick Disease Type C